PUMA BIOTECHNOLOGY INC (PBYI)

US74587V1070 - Common Stock

5.31  -0.27 (-4.84%)

Buy % Consensus

48

ChartMill assigns a Buy % Consensus number of 48% to PBYI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.42. This target is -16.76% below the current price.
PBYI was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about PBYI.
In the previous month the buy percentage consensus was at a similar level.
PBYI was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 5.312.024.084.427.35 - -61.96% -23.16% -16.76% 38.42%
Up and Down Grades
Date Firm Action Rating
2024-03-01 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-04 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-05 HC Wainwright & Co. Reiterate Buy
2023-03-06 HC Wainwright & Co. Reiterate Buy
2022-08-05 HC Wainwright & Co. Maintains Buy
2022-05-06 HC Wainwright & Co. Maintains Buy
2021-09-28 Citigroup Upgrade Neutral -> Buy
2021-08-06 RBC Capital Maintains Sector Perform
2021-08-06 Goldman Sachs Maintains Sell